Experimental drug targets hidden cholesterol pathway after passing safety trial

Scientists have discovered a biological mechanism that allows high cholesterol diets to weaken the body's natural cholesterol defenses, ScienceDaily reported. By blocking this specific pathway, researchers successfully lowered harmful LDL cholesterol levels in mice. [1]

An experimental medication designed to block this driver has already successfully passed an early human safety trial, according to ScienceDaily. The positive safety results could accelerate the development of a novel treatment for individuals living with elevated cholesterol levels. [1]

Heart disease related to elevated cholesterol remains the leading cause of death globally, ScienceDaily noted. Many individuals continue to struggle to bring their cholesterol down to safe levels using existing treatments, while others experience adverse side effects from available therapies. [1]

As HEROIC BREAKING NEWS reported earlier, common statin medications can trigger muscle pain and weakness by attaching to a muscle cell protein and altering calcium control. The newly tested pathway offers potential alternative options for patients who cannot tolerate standard statin drugs. [1][3]